Mark E Saad insider trades: Axsome Therapeutics (AXSM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | AXSM | ↓ Sell | 37,577 | $165.18 | $6.2M | Direct | Jan 2, 2026 (2d) |
| Sep 5, 2025 | AXSM | ↓ Sell | 9,127 | $125.07 | $1.1M | Direct | Sep 5, 2025 (0d) |
| Sep 11, 2024 | AXSM | ↓ Sell | 11,016 | $91.31 | $1.0M | Direct | Sep 11, 2024 (0d) |
| Nov 17, 2021 | AXSM | ↑ Buy | 3,000 | $34.53 | $104K | Direct | Nov 19, 2021 (2d) |
| Nov 17, 2021 | AXSM | ↑ Buy | 300 | $34.41 | $10K | Custodial account for child | Nov 19, 2021 (2d) |
| May 23, 2019 | AXSM | ↑ Buy | 3,500 | $22.33 | $78K | Direct | May 24, 2019 (1d) |
| Mar 14, 2012 | CYTX | ↑ Buy | 10,000 | $2.55 | $25K | Direct | Mar 14, 2012 (0d) |
| Aug 12, 2011 | CYTX | ↑ Buy | 6,500 | $3.12 | $20K | Direct | Aug 12, 2011 (0d) |
| May 21, 2010 | CYTX | ↑ Buy | 6,000 | $4.29 | $26K | Direct | May 21, 2010 (0d) |
| Aug 12, 2008 | CYTX | ↑ Buy | 15,000 | $6.69 | $100K | Direct | Aug 12, 2008 (0d) |
| Sep 5, 2006 | CYTX | ↑ Buy | 1,850 | $5.08 | $9K | Direct | Sep 7, 2006 (2d) |
| Sep 1, 2006 | CYTX | ↑ Buy | 2,300 | $5.37 | $12K | Direct | Sep 5, 2006 (4d) |
| Aug 30, 2006 | CYTX | ↑ Buy | 1,550 | $5.31 | $8K | Direct | Aug 30, 2006 (0d) |
| Aug 28, 2006 | CYTX | ↑ Buy | 1,600 | $5.09 | $8K | Direct | Aug 28, 2006 (0d) |
| Aug 24, 2006 | CYTX | ↑ Buy | 1,700 | $4.45 | $8K | Direct | Aug 24, 2006 (0d) |
| Aug 22, 2006 | CYTX | ↑ Buy | 2,500 | $4.40 | $11K | Direct | Aug 22, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AXSM insiders
Open-market trades in the last 12 months
About Mark E Saad's insider trades
Mark E Saad is an insider at Axsome Therapeutics (AXSM). Since Aug 22, 2006, Mark has reported 13 open-market purchases worth $421K and 3 sales worth $8.4M on SEC Form 4. In the last 12 months: 1 sale ($6.2M).
Their filings also include grants and awards (36 filings), option exercises (4 filings), shares returned to the company (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXSM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.